Company · founded 2005
Expression Therapeutics (United States)
Tucker, United States · expressiontherapeutics.com
- Citations, last 5 years
- 64
- Works, last 5 years
- 15
- h-index
- 19
- Scientists listed
- 1
- Grants since 2016
- 7
Grants received
2024–2025 · research · R43
Allogeneic cell and gene therapy for neuroendocrine tumors
Christopher Bradley Doering · Expression Therapeutics (United States) · funded by National Institutes of Health
2023–2024 · research · R43
ADEPT-STAR therapy for high risk neuroblastoma
Christopher Bradley Doering · Expression Therapeutics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
A Microscale Platform for Augmentation of Cell Transduction (MPACT) to Enhance Ex Vivo Gene Transfer
Gabriela Denning · Expression Therapeutics (United States) · funded by National Institutes of Health
2017–2018 · research · R43
Preclinical Evaluation of Ancestral Coagulation Factor VIII
Gabriela Denning · Expression Therapeutics (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Selection and preclinical validation of a lead candidate liver-directed AAV-FVIII expression cassette
Gabriela Denning · Expression Therapeutics (United States) · funded by National Institutes of Health
2012–2022 · research · R44
Clinical Testing of the First Suspension BHK-M Cell Platform Derived Biotherapeutic
Gabriela Denning · Expression Therapeutics (United States) · funded by National Institutes of Health
2012–2020 · research · R44
Clinical Testing of the First Suspension BHK-M Cell Platform Derived Biotherapeutic
Gabriela Denning · Expression Therapeutics (United States) · funded by National Institutes of Health
